Table 4. The KEGG pathways associated with the analysed genes, highlighting their involvement in specific biological pathways and networks.
| Category | Term | RT | Count | % | P-value | Benjamini |
|---|---|---|---|---|---|---|
| KEGG_PATHWAY | Antigen processing and presentation | RT | 8 | 5.7 | 6.9E−7 | 1.1E−4 |
| KEGG_PATHWAY | Graft-vs-host disease | RT | 6 | 4.3 | 7.5E−6 | 5.7E−4 |
| KEGG_PATHWAY | Natural killer cell-mediated cytotoxicity | RT | 6 | 4.3 | 1.5E−3 | 7.4E−2 |
| KEGG_PATHWAY | Estrogen signalling pathway | RT | 5 | 3.5 | 1.3E−2 | 4.9E−1 |
| KEGG_PATHWAY | Allograft rejection | RT | 3 | 2.1 | 2.6E−2 | 7.9E−1 |
| KEGG_PATHWAY | Type I diabetes mellitus | RT | 3 | 2.1 | 3.3E−2 | 8.3E−1 |
| KEGG_PATHWAY | Autoimmune thyroid disease | RT | 3 | 2.1 | 4.8E−2 | 1.0E0 |
| KEGG_PATHWAY | Human T-cell leukemia virus 1 infection | RT | 5 | 3.5 | 5.9E−2 | 1.0E0 |
| KEGG_PATHWAY | Viral myocarditis | RT | 3 | 2.1 | 6.0E−2 | 1.0E0 |